The 1.8 Å crystal structure of ACTIBIND suggests a mode of action for T2 ribonucleases as antitumorigenic agents. [electronic resource]
Producer: 20120423Description: 1013-20 p. digitalISSN:- 1520-4804
- Actins -- chemistry
- Amino Acid Sequence
- Angiogenesis Inhibitors -- chemistry
- Aspergillus niger -- chemistry
- Bacterial Proteins -- chemistry
- Binding Sites
- Crystallography, X-Ray
- Glycoproteins -- chemistry
- Glycosylation
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Models, Molecular
- Molecular Sequence Data
- Protein Conformation
- Ribonucleases -- chemistry
- Sequence Alignment
- Tumor Suppressor Proteins -- chemistry
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.